Singapore markets closed
Straits Times Index
3,265.95 +1.42 (+0.04%) S&P 500
5,187.67 -0.03 (-0.00%) Dow
39,056.39 +172.13 (+0.44%) Nasdaq
16,302.76 -29.80 (-0.18%) Bitcoin USD
60,982.11 -1,445.39 (-2.32%) CMC Crypto 200
1,319.52 +19.42 (+1.49%)
Aileron Therapeutics, Inc. (ALRN)
NasdaqCM - NasdaqCM Real-time price. Currency in USD
Add to watchlist
At close: 04:00PM EDT
Currency in USD
Valuation measures4
| Market cap (intra-day) | 77.17M |
| Enterprise value | 59.90M |
| Trailing P/E | N/A |
| Forward P/E | N/A |
| PEG ratio (5-yr expected) | N/A |
| Price/sales (ttm) | N/A |
| Price/book (mrq) | 11.20 |
| Enterprise value/revenue | N/A |
| Enterprise value/EBITDA | -3.93 |
Trading information
Stock price history
| Beta (5Y monthly) | 2.31 |
| 52-week change 3 | 144.97% |
| S&P500 52-week change 3 | 25.59% |
| 52-week high 3 | 7.4200 |
| 52-week low 3 | 1.0100 |
| 50-day moving average 3 | 5.2896 |
| 200-day moving average 3 | 3.1712 |
Share statistics
| Avg vol (3-month) 3 | 90.02k |
| Avg vol (10-day) 3 | 179.48k |
| Shares outstanding 5 | 16.87M |
| Implied shares outstanding 6 | 21.14M |
| Float 8 | 16.81M |
| % held by insiders 1 | 0.16% |
| % held by institutions 1 | 14.70% |
| Shares short (15 Apr 2024) 4 | 43.41k |
| Short ratio (15 Apr 2024) 4 | 1.17 |
| Short % of float (15 Apr 2024) 4 | 0.27% |
| Short % of shares outstanding (15 Apr 2024) 4 | 0.26% |
| Shares short (prior month 15 Mar 2024) 4 | 32.95k |
Dividends & splits
| Forward annual dividend rate 4 | N/A |
| Forward annual dividend yield 4 | N/A |
| Trailing annual dividend rate 3 | 0.00 |
| Trailing annual dividend yield 3 | 0.00% |
| 5-year average dividend yield 4 | N/A |
| Payout ratio 4 | 0.00% |
| Dividend date 3 | N/A |
| Ex-dividend date 4 | N/A |
| Last split factor 2 | 1:20 |
| Last split date 3 | 11 Nov 2022 |
Financial highlights
Fiscal year
| Fiscal year ends | 31 Dec 2023 |
| Most-recent quarter (mrq) | 31 Dec 2023 |
Profitability
| Profit margin | 0.00% |
| Operating margin (ttm) | 0.00% |
Management effectiveness
| Return on assets (ttm) | -14.99% |
| Return on equity (ttm) | -26.91% |
Income statement
| Revenue (ttm) | N/A |
| Revenue per share (ttm) | N/A |
| Quarterly revenue growth (yoy) | N/A |
| Gross profit (ttm) | N/A |
| EBITDA | -15.23M |
| Net income avi to common (ttm) | -15.73M |
| Diluted EPS (ttm) | -3.4200 |
| Quarterly earnings growth (yoy) | N/A |
Balance sheet
| Total cash (mrq) | 17.31M |
| Total cash per share (mrq) | 1.02 |
| Total debt (mrq) | 48k |
| Total debt/equity (mrq) | 0.05% |
| Current ratio (mrq) | 4.17 |
| Book value per share (mrq) | 1.41 |
Cash flow statement
| Operating cash flow (ttm) | -19.81M |
| Levered free cash flow (ttm) | -7.62M |
© 2024 Yahoo. All rights reserved.